Market Place
Sourcing Support
Alpha-9 Oncology Initiates Phase 1 Trial For A9-3408 In Melanoma
04 Dec 2025 //
PR NEWSWIRE
Alpha-9 Oncology Names Paul Blanchfield at CEO
10 Nov 2025 //
PR NEWSWIRE
ITM, Alpha-9 Oncology Sign Actinium-225 Supply Agreement
24 Apr 2025 //
GLOBENEWSWIRE
Alpha-9 Oncology Secures $175 Million For Clinical Pipeline
23 Oct 2024 //
PR NEWSWIRE
Alpha-9 Oncology Appoints Jean-Jacques and Dr. Steven to its BoD
15 Oct 2024 //
PR NEWSWIRE
Alpha-9 Doses First Patient In Phase 1 A9-3202 Melanoma Study
02 May 2024 //
PR NEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.